Nh-Amundi Hanaro Bio Korea Active Etf Fund

NH-Amundi Bio Korea Active ETF is an actively managed exchange-traded fund that primarily focuses on the biotechnology sector within South Korea. The ETF seeks to deliver investment results that correspond to the performance of the Korean biopharmaceutical and healthcare industries by investing in a diversified portfolio of companies engaged in innovative technologies and advancements in biotechnology. With a focus on healthcare, pharmaceuticals, and biotech firms, this ETF provides exposure to key players and innovators within these dynamic sectors, which are vital to addressing global health challenges and developing cutting-edge medical solutions. The fund supports investors seeking to capitalize on the growth potential of biotechnology advancements specific to the South Korean market. As part of the broader Amundi asset management group, one of Europe’s largest asset managers, it benefits from extensive research capabilities and market insights, positioning it as a significant instrument for investors interested in gaining targeted exposure to South Korea's thriving life sciences industry.